Lv4
570 积分 2022-10-10 加入
An exploration of gastric cancer with heterogeneous mismatch repair status
7天前
已完结
Targeting HER2 heterogeneity in breast and gastrointestinal cancers
14天前
已完结
What About Variant Histologies in Bladder Cancer?
1个月前
已完结
Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention
1个月前
已完结
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
1个月前
已完结
Contemporary management of advanced gastric and gastroesophageal adenocarcinomas
1个月前
已完结
Correlation between trophoblast cell-surface antigen-2 (Trop-2) expression and pathological complete response in patients with HER2-positive early breast cancer treated with neoadjuvant docetaxel, carboplatin, trastuzumab, and pertuzumab
2个月前
已完结
Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer: The ORIENT-16 Randomized Clinical Trial
2个月前
已完结
Cadonilimab with chemotherapy in HER2-negative gastric or gastroesophageal junction adenocarcinoma: the phase 1b/2 COMPASSION-04 trial
2个月前
已完结
The Conflicting Prognostic Role of the Stroma-Tumor Ratio in Breast Cancer Molecular Subtypes
3个月前
已关闭
皖公网安备34019202002308
